Relation between body fat and liver fat accumulation and cytokine pattern in non-alcoholic patients with chronic HCV infection

Annals of Nutrition and Metabolism

Volumn 55, Issue 4, 2009, Pages 351-357

  Gonzalez Reimers E ^a   Castellano Higuera, A ^a   Aleman Valls R ^a   Alvarez Arguelles H ^a   De La Vega Prieto, M J ^a   Abreu Gonzalez P ^b   Lopez Prieto J ^a   Santolaria Fernandez F ^a   Valladares Parrilla, F ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Body fat liver fat; Hepatitis C virus; Human immunodeficiency virus; Lipid peroxidation; Pro inflammatory cytokines; Steatohepatitis

Indexed keywords

ADIPONECTIN; GAMMA INTERFERON; GLUTATHIONE PEROXIDASE; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD LEVEL; BODY FAT DISTRIBUTION; BODY MASS; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; FATTY LIVER; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAABDOMINAL FAT; LIPID LIVER LEVEL; LIPID STORAGE; LIVER BIOPSY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SKINFOLD THICKNESS; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE;

ADIPOKINES; ADIPOSE TISSUE; ADULT; BODY MASS INDEX; CYTOKINES; FATTY LIVER; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; OXIDATIVE STRESS; SEVERITY OF ILLNESS INDEX; TISSUE INHIBITOR OF METALLOPROTEINASE-1; WAIST CIRCUMFERENCE;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 70350152410     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000252351     Document Type: Article

References (30)

1. Knodell KG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435.
2. Bedossa P, Bioulac-Sage P, Callard P, Chevallier M, Degott C, Deugnier C and the French Metavir cooperative Study Group: Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.
3. Negro F: Mechanisms and significance of liver steatosis in hepatitis C virus infection. World J Gastroenterol 2006; 12: 6756-6765.
4. Barba G, Harper F, Harada T, Kohara M, Goulinet S, Matsuura Y, Eder G, Scaff Z, Chapman MJ, Miyamura T, Bréchot C: Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci USA 1997; 94: 1200-1205.
5. Björnsson E, Angulo P: Hepatitis C and steatosis. Arch Med Res 2007; 38: 621-627.
6. Diehl AM: Obesity and alcoholic liver disease. Alcohol 2004; 34: 81-87.
7. Lieber CS: Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004; 34: 9-19.
8. El-Serag HB, Tran T, Everhart JE: Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460-468.
9. Sutinen J, Korsheninnikova E, Funahashi T, Matzusawa Y, Nyman T, Yki-Järvinen H: Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy. J Clin Endocrinol Metab 2003; 88: 1907-1910.
10. Sheikh MY, Choi J, Qadri I, Friedman JE, Sanyal AJ: Hepatitis C virus infection: molecular pathways to metabolic syndrome. Hepatology 2008; 47: 2127-2133.
11. McClain CJ, Mokshagundam SPL, Barve SS, Song Z, Hill DB, Chen T, Deaciuc I: Mechanisms of non-alcoholic steatohepatitis. Alcohol 2004; 34: 67-79.
12. Xu A, Wang Y, Keshaw H, Xu LY, Lam KSL, Cooper GJS: The fat-derived hormone adiponectin alleviates alcoholic and non-alcoholic fatty liver diseases in mice. J Clin Invest 2003; 112: 91-100.
13. Sorensen IV, Fenger C, Winther H, Foged NT, Lademan U, Brünner N, Usher PA: Characterization of anti-TIMP-1 monoclonal antibodies for immunohistochemical localization in Formalin-fixed, Paraffin-embedded tissue. J Histochem Cytochem 2006; 54: 1075-1086.
14. Kikugawa K, Kojima T, Yamaki S, Kosugi H: Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylediaminotetraacetic acid. Anal Biochem 1992; 202: 249-255.
15. Adler M, Schaffner F: Fatty liver, hepatitis and cirrosis in obese patients. Am J Med 1979; 67: 811-816.
16. Abrams GA, Kunde SS, Lazenby AJ, Clements RH: Portal fibrosis and hepatic steatosis in morbity obese subjects: a spectrum of non-alcoholic fatty liver disease. Hepatology 2004; 40: 475-483.
17. Ludwig J, Viggiano TR, McGill DB, Oh BJ: Non alcoholic steatohepatitis: mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-438.
18. Rubbia-Brandt L, Quadri R, Abid K, Giostra E, Malé PJ, Mentha G, Spahr L, Zarski JP, Borisch B, Hadengue A, Negro F: Hepatocyte steatosis is a cytopathic effect of hepatitis C genotype 3. J Hepatol 2000; 33: 106-115.
19. Fartoux L, Poujol-Robert A, Guéchot J, Wendum D, Poupon R, Serfaty L: Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut 2005; 54: 1003-1008. (Pubitemid 40873917)
20. Gutiérrez-Reyes G, Gutiérrez-Ruiz MC, Khersenobich D: Liver fibrosis and chronic viral hepatitis. Arch Med Res 2007; 38: 644-651.
21. Ko WS, Guo CH, Yeh MS, Lin LY, Hsu GS, Chen PC, Luo MC, Lin CY: Blood micronutrient, oxidative stress, and viral load in patients with chronic hepatitis C. World J Gastroenterol 2005; 11: 4697-4702
22. Wajchenberg BL, Gianella-Neto D, da Silva MER, Santos RF: Depot-specific hormonal characteristics of subcutaneous fat and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res 2002; 34: 616-621.
23. Maury E, Ehala-Aleksejev K, Guiot Y, Detry R, Vandenhooft A, Brichard SM: Adipokines oversecreted by omental adipose tissue in human obesity. Am J Physiol Endocrinol Metab 2007; 293:E656-E665.
24. González-Reimers E, García-Valdecasas E, Santolaria-Fernández F, de la Vega-Prieto MJ, Ros-Vilamajó R, Martínez-Riera A, Rodríguez-Gaspar M: Proinflammatory cytokines in stable chronic alcoholics: relationships with lean and fat mass. Food Chem Toxicol 2007; 45: 904-909.
25. Sánchez-Pérez MJ, González-Reimers E, Santolaria-Fernández F, de La Vega-Prieto MJ, Martínez-Riera A, González-Abreu P, Rodríguez-Rodríguez E, Durán-Castellón MC: Lipid peroxidation and serum cytokines in acute alcoholic hepatitis. Alcohol Alcohol 2006; 41:593-597.
26. Nelson DR, González-Peralta RP, Qian K, Xu Y, Marousis CG, Davis GL, Lau JY: Transforming growth factor-beta 1 in chronic hepatitis C. J Viral Hepatitis 1997; 4: 29-35.
27. Neuman MG, Benhamou JP, Malkiewicz IM, Ibrahim A, Valla DC, Martinot-Peignoux M, Asselah T, Bourliere M, Katz GG, Shear NH, Marcellin P: Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis. J Viral Hepatitis 2002; 9: 134-140.
28. Spanakis NE, Garinis GA, Alexopoulos EC, Patrinos GP, Menounos PG, Sklavounou A, Manolis EN, Gorgoulis VG, Valis D: Cytokine serum levels in patients with chronic HCV infection. J Clin Lab Anal 2002; 16: 40-46.
29. Roulot D, Durand H, Coste T, Rautureau J, Strosberg AD, Benarous R, Marullo S: Quantitative analysis of transforming growth factor beta 1 messenger RNA in the liver of patients with chronic hepatitis C: absence of correlation between high levels and severity of disease. Hepatology 1995; 21: 298-304.
30. Benyon RC, Arthur MJ: Extracellular matrix degradation and the role of hepatic stellate cells. Sem Liver Dis 2001; 21: 373-384.